76 studies found for:    IL-7 AND HIV
Show Display Options
Rank Status Study
1 Completed Safety Study of IL-7 in HIV-infected Patients (Inspire)
Conditions: HIV Infections;   Lymphopenia
Intervention: Drug: CYT 107
2 Completed Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs
Condition: HIV Infections
Intervention: Drug: Recombinant human interleukin-7
3 Terminated Study on Interleukin-7 (CYT107) in HIV Patients
Condition: HIV
Intervention: Biological: Interleukin-7
4 Completed Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment
Conditions: HIV Infections;   HIV
Intervention: Drug: IL-7
5 Terminated Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders
Condition: HIV
Intervention: Drug: CYT107
6 Completed IL-7 Receptor Polymorphisms and Immune Recovery With HAART
Condition: HIV Infections
Intervention:
7 Terminated Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)
Condition: Idiopathic CD4+ T-Lymphocytopenia
Intervention: Drug: CYT107
8 Completed Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients
Condition: HIV-1 Infection
Interventions: Drug: ART Intensification;   Biological: Immunomodulation
9 Withdrawn Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma
Conditions: Hodgkin Lymphoma;   Stage I Adult Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma
Interventions: Drug: lopinavir;   Drug: ritonavir;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: enzyme-linked immunosorbent assay;   Other: laboratory biomarker analysis
10 Active, not recruiting Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
Condition: Chronic Hepatitis B
Interventions: Drug: CYT107+GenHevac+entecavir or tenofovir;   Drug: CYT107+ entecavir or tenofovir
11 Recruiting Idiopathic CD4 Lymphocytopenia
Condition: Idiopathic CD4 Lymphocytopenia
Interventions: Biological: Constitution of a biobank of frozen cells, plasma and serum samples;   Genetic: Genetic study
12 Active, not recruiting Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies
Conditions: Hodgkin Lymphoma;   Lymphocytic Leukemia;   Mixed Cell Leukemia;   Myelodysplastic Syndrome;   Non Hodgkin's Lymphoma;   CML;   ALL;   AML;   Lymphoma
Intervention: Procedure: Stem cell transplantation
13 Completed Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults
Condition: HIV Infections
Interventions: Biological: HIV-1 gag DNA;   Biological: IL-15 DNA adjuvant;   Biological: IL-12 DNA adjuvant
14 Completed Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults
Condition: HIV Infections
Interventions: Biological: HIV-1 gag DNA;   Biological: HIV-1 gag DNA plus IL-12 DNA adjuvant;   Biological: CTL MEP/RC529-SE/GM-CSF (CTL MEP vaccine);   Biological: Sodium chloride injection (0.9%)
15 Completed
Has Results
Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression
Condition: HIV Infections
Intervention: Drug: Maraviroc
16 Completed
Has Results
Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART
Condition: HIV Infections
Interventions: Biological: LC002 standard vaccination;   Biological: LC002 high-dose vaccination;   Biological: LC002 placebo vaccination
17 Completed
Has Results
Rifaximin as a Modulator of Microbial Translocation and Immune Activation
Condition: HIV-1 Infection
Intervention: Drug: Rifaximin
18 Terminated Novel Interventions in HIV-1 Infection
Condition: HIV-1 Infection
Interventions: Biological: GTU-MultiHIV B clade vaccine1mg;   Drug: Interleukin-2;   Drug: GM-CSF;   Drug: Growth Hormone
19 Completed Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults
Condition: HIV Infections
Interventions: Biological: DNA Vaccine;   Biological: Placebo;   Biological: rMVA vaccine
20 Completed
Has Results
Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People
Condition: HIV Infections
Intervention: Drug: IL-2

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years